Progress toward personalized medicine for glaucoma
How will you respond when a patient asks, "Doctor, what can I do to prevent myself from going blind from glaucoma like mom?". There is optimism that genetic profiling will help target patients to individualized treatments based on validated disease risk alleles, validated pharmacogenetic m...
Gespeichert in:
| Veröffentlicht in: | Expert Review of Ophthalmology 2009-04, Vol.4 (2), p.145-161 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 161 |
|---|---|
| container_issue | 2 |
| container_start_page | 145 |
| container_title | Expert Review of Ophthalmology |
| container_volume | 4 |
| creator | Moroi, Sayoko E Raoof, Duna A Reed, David M Zöllner, Sebastian Qin, Zhaohui Richards, Julia E |
| description | How will you respond when a patient asks, "Doctor, what can I do to prevent myself from going blind from glaucoma like mom?". There is optimism that genetic profiling will help target patients to individualized treatments based on validated disease risk alleles, validated pharmacogenetic markers and behavioral modification. Personalized medicine will become a reality through identification of disease and pharmacogenetic markers, followed by careful study of how to employ this information in order to improve treatment outcomes. With advances in genomic technologies, research has shifted from the simple monogenic disease model to a complex multigenic and environmental disease model to answer these questions. Our challenges lie in developing risk models that incorporate gene-gene interactions, gene copy-number variations, environmental interactions, treatment effects and clinical covariates. |
| doi_str_mv | 10.1586/eop.09.6 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3728985</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A224248245</galeid><sourcerecordid>A224248245</sourcerecordid><originalsourceid>FETCH-LOGICAL-c525t-5f0d33c8fc9029915a86066ae1d3d3afa869e8ed551517a2f32e5663af8efd113</originalsourceid><addsrcrecordid>eNptkctuFDEQRS0EIiEg8QWoxYrNDH603fYGKYp4SZFgAWursMszjtztwe5OFL4ejyYJCSAv_KhTt265CHnJ6JpJrd5i3q2pWatH5JgNvVoZQ_nj27M25og8q_WCUil0z5-SIy4M67nkx4R_LXlTsNZuzldQfLfDUvMEKf5C343oo4sTdiGXbpNgcXmE5-RJgFTxxc1-Qr5_eP_t7NPq_MvHz2en5ysnuZxXMlAvhNPBNTPGMAlaUaUAmRdeQGhXgxq9lEyyAXgQHKVSLaIxeMbECXl30N0tP5oRh9NcINldiSOUa5sh2oeRKW7tJl9aMXBttGwCb24ESv65YJ3tGKvDlGDCvFTLNFdyGBjd13r9F3qRl9K-oVo9CCmE4H2D1gdoAwltnEJuZV1bHsfo8oQhtvdTznvea97fM-BKrrVguDPPqN0PzrbBWWqsauir-83egbeTaoA4APu6ZYSrXJK3M1ynXEKBycVqxX9k-YOsLUKatw4K_mnwn6TfWBi3RA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>873533324</pqid></control><display><type>article</type><title>Progress toward personalized medicine for glaucoma</title><source>Alma/SFX Local Collection</source><creator>Moroi, Sayoko E ; Raoof, Duna A ; Reed, David M ; Zöllner, Sebastian ; Qin, Zhaohui ; Richards, Julia E</creator><creatorcontrib>Moroi, Sayoko E ; Raoof, Duna A ; Reed, David M ; Zöllner, Sebastian ; Qin, Zhaohui ; Richards, Julia E</creatorcontrib><description>How will you respond when a patient asks, "Doctor, what can I do to prevent myself from going blind from glaucoma like mom?". There is optimism that genetic profiling will help target patients to individualized treatments based on validated disease risk alleles, validated pharmacogenetic markers and behavioral modification. Personalized medicine will become a reality through identification of disease and pharmacogenetic markers, followed by careful study of how to employ this information in order to improve treatment outcomes. With advances in genomic technologies, research has shifted from the simple monogenic disease model to a complex multigenic and environmental disease model to answer these questions. Our challenges lie in developing risk models that incorporate gene-gene interactions, gene copy-number variations, environmental interactions, treatment effects and clinical covariates.</description><identifier>ISSN: 1746-9899</identifier><identifier>EISSN: 1746-9902</identifier><identifier>DOI: 10.1586/eop.09.6</identifier><identifier>PMID: 23914252</identifier><language>eng</language><publisher>England: Informa Healthcare</publisher><subject>Anopheles ; aqueous humor dynamics ; genetics ; Glaucoma ; intraocular pressure ; personalized medicine ; pharmacogenetics ; pharmacogenomics ; Precision medicine</subject><ispartof>Expert Review of Ophthalmology, 2009-04, Vol.4 (2), p.145-161</ispartof><rights>Expert Reviews Ltd 2009</rights><rights>COPYRIGHT 2009 Expert Reviews Ltd.</rights><rights>2009 © Expert Reviews Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c525t-5f0d33c8fc9029915a86066ae1d3d3afa869e8ed551517a2f32e5663af8efd113</citedby><cites>FETCH-LOGICAL-c525t-5f0d33c8fc9029915a86066ae1d3d3afa869e8ed551517a2f32e5663af8efd113</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,313,314,780,784,792,885,27922,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23914252$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moroi, Sayoko E</creatorcontrib><creatorcontrib>Raoof, Duna A</creatorcontrib><creatorcontrib>Reed, David M</creatorcontrib><creatorcontrib>Zöllner, Sebastian</creatorcontrib><creatorcontrib>Qin, Zhaohui</creatorcontrib><creatorcontrib>Richards, Julia E</creatorcontrib><title>Progress toward personalized medicine for glaucoma</title><title>Expert Review of Ophthalmology</title><addtitle>Expert Rev Ophthalmol</addtitle><description>How will you respond when a patient asks, "Doctor, what can I do to prevent myself from going blind from glaucoma like mom?". There is optimism that genetic profiling will help target patients to individualized treatments based on validated disease risk alleles, validated pharmacogenetic markers and behavioral modification. Personalized medicine will become a reality through identification of disease and pharmacogenetic markers, followed by careful study of how to employ this information in order to improve treatment outcomes. With advances in genomic technologies, research has shifted from the simple monogenic disease model to a complex multigenic and environmental disease model to answer these questions. Our challenges lie in developing risk models that incorporate gene-gene interactions, gene copy-number variations, environmental interactions, treatment effects and clinical covariates.</description><subject>Anopheles</subject><subject>aqueous humor dynamics</subject><subject>genetics</subject><subject>Glaucoma</subject><subject>intraocular pressure</subject><subject>personalized medicine</subject><subject>pharmacogenetics</subject><subject>pharmacogenomics</subject><subject>Precision medicine</subject><issn>1746-9899</issn><issn>1746-9902</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNptkctuFDEQRS0EIiEg8QWoxYrNDH603fYGKYp4SZFgAWursMszjtztwe5OFL4ejyYJCSAv_KhTt265CHnJ6JpJrd5i3q2pWatH5JgNvVoZQ_nj27M25og8q_WCUil0z5-SIy4M67nkx4R_LXlTsNZuzldQfLfDUvMEKf5C343oo4sTdiGXbpNgcXmE5-RJgFTxxc1-Qr5_eP_t7NPq_MvHz2en5ysnuZxXMlAvhNPBNTPGMAlaUaUAmRdeQGhXgxq9lEyyAXgQHKVSLaIxeMbECXl30N0tP5oRh9NcINldiSOUa5sh2oeRKW7tJl9aMXBttGwCb24ESv65YJ3tGKvDlGDCvFTLNFdyGBjd13r9F3qRl9K-oVo9CCmE4H2D1gdoAwltnEJuZV1bHsfo8oQhtvdTznvea97fM-BKrrVguDPPqN0PzrbBWWqsauir-83egbeTaoA4APu6ZYSrXJK3M1ynXEKBycVqxX9k-YOsLUKatw4K_mnwn6TfWBi3RA</recordid><startdate>20090401</startdate><enddate>20090401</enddate><creator>Moroi, Sayoko E</creator><creator>Raoof, Duna A</creator><creator>Reed, David M</creator><creator>Zöllner, Sebastian</creator><creator>Qin, Zhaohui</creator><creator>Richards, Julia E</creator><general>Informa Healthcare</general><general>Taylor & Francis</general><general>Expert Reviews Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20090401</creationdate><title>Progress toward personalized medicine for glaucoma</title><author>Moroi, Sayoko E ; Raoof, Duna A ; Reed, David M ; Zöllner, Sebastian ; Qin, Zhaohui ; Richards, Julia E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c525t-5f0d33c8fc9029915a86066ae1d3d3afa869e8ed551517a2f32e5663af8efd113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Anopheles</topic><topic>aqueous humor dynamics</topic><topic>genetics</topic><topic>Glaucoma</topic><topic>intraocular pressure</topic><topic>personalized medicine</topic><topic>pharmacogenetics</topic><topic>pharmacogenomics</topic><topic>Precision medicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moroi, Sayoko E</creatorcontrib><creatorcontrib>Raoof, Duna A</creatorcontrib><creatorcontrib>Reed, David M</creatorcontrib><creatorcontrib>Zöllner, Sebastian</creatorcontrib><creatorcontrib>Qin, Zhaohui</creatorcontrib><creatorcontrib>Richards, Julia E</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Expert Review of Ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moroi, Sayoko E</au><au>Raoof, Duna A</au><au>Reed, David M</au><au>Zöllner, Sebastian</au><au>Qin, Zhaohui</au><au>Richards, Julia E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Progress toward personalized medicine for glaucoma</atitle><jtitle>Expert Review of Ophthalmology</jtitle><addtitle>Expert Rev Ophthalmol</addtitle><date>2009-04-01</date><risdate>2009</risdate><volume>4</volume><issue>2</issue><spage>145</spage><epage>161</epage><pages>145-161</pages><issn>1746-9899</issn><eissn>1746-9902</eissn><abstract>How will you respond when a patient asks, "Doctor, what can I do to prevent myself from going blind from glaucoma like mom?". There is optimism that genetic profiling will help target patients to individualized treatments based on validated disease risk alleles, validated pharmacogenetic markers and behavioral modification. Personalized medicine will become a reality through identification of disease and pharmacogenetic markers, followed by careful study of how to employ this information in order to improve treatment outcomes. With advances in genomic technologies, research has shifted from the simple monogenic disease model to a complex multigenic and environmental disease model to answer these questions. Our challenges lie in developing risk models that incorporate gene-gene interactions, gene copy-number variations, environmental interactions, treatment effects and clinical covariates.</abstract><cop>England</cop><pub>Informa Healthcare</pub><pmid>23914252</pmid><doi>10.1586/eop.09.6</doi><tpages>17</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1746-9899 |
| ispartof | Expert Review of Ophthalmology, 2009-04, Vol.4 (2), p.145-161 |
| issn | 1746-9899 1746-9902 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3728985 |
| source | Alma/SFX Local Collection |
| subjects | Anopheles aqueous humor dynamics genetics Glaucoma intraocular pressure personalized medicine pharmacogenetics pharmacogenomics Precision medicine |
| title | Progress toward personalized medicine for glaucoma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T00%3A44%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Progress%20toward%20personalized%20medicine%20for%20glaucoma&rft.jtitle=Expert%20Review%20of%20Ophthalmology&rft.au=Moroi,%20Sayoko%20E&rft.date=2009-04-01&rft.volume=4&rft.issue=2&rft.spage=145&rft.epage=161&rft.pages=145-161&rft.issn=1746-9899&rft.eissn=1746-9902&rft_id=info:doi/10.1586/eop.09.6&rft_dat=%3Cgale_pubme%3EA224248245%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=873533324&rft_id=info:pmid/23914252&rft_galeid=A224248245&rfr_iscdi=true |